205
Views
89
CrossRef citations to date
0
Altmetric
Research Article

Enuresis - Background and Treatment

, , , , &
Pages 1-44 | Published online: 09 Jul 2009

REFERENCES

  • Mattsson S, Lindström S. Diuresis and voiding pattern in healthy schoolchildren. Br J Urol 1994; 76 (6): 783–9.
  • Mattsson S. Voiding frequency, volumes and intervals in healthy schoolchildren. Scand J Urol Nephrol 1994; 28: 1–11.
  • Thompson CJ, Baylis PH. Reproducibility of osmoti-cally stimulated thirst and vasopressin release (abstract). J Endocrinol 1987; 112 (Suppl): 69.
  • Thrasher TN, Keil LC. Regulation of drinking and vasopressin secretion: role of the organum vasculosum laminae terminalis. Am J Physiol 1987; 253: R108–12.
  • Thrasher TN. Role of forebrain circumventricular organs in body fluid balance. Acta Physiol Scand 1989; 136 (Suppl 583): 141–50.
  • Vallotton MB, Merkelbach U, Claillard LC. Studies of the factors modulating antidiuretic hormone excretion in man in response to the osmolar stimulus: effects of oestrogen and angiotensin II. Acta Endocrinol (Copenh) 1983; 104: 295–9.
  • Schnermann J. Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol 1998; 274 (Regulatory Integrative Comp Physiol 43): R263–79.
  • Skein O, Briggs JP. Direct demonstration of macula densa-mediated renin secretion. Science 1987; 237: 1618–20.
  • Thomson SC, Blantz RC, Vallon V. Increased tubular flow induces resetting of tubuloglomerular feedback in euvolemic rats. Am J Physiol 1996; 270 (Renal Fluid Electrolyte Physiol 39): F461–8.
  • Schneerman J, Briggs JP. Single nephron comparison of the effect of loop of Bente flow on filtration rate and pressure in control and angiotensin II-infused rats. Miner Electrolyte Metab 1989; 15: 103–7.
  • Schnermann J, Briggs JP. The function of the juxta-glomerular apparatus: control of glomerular hemody-namics and renin secretion. In: Seldin DW, Giebisch G, ed. The Kidney: physiology and pathophysiology. 2nd ed. New York: Raven, 1992; 1: 1249–89.
  • Davis JO, Freeman RH. Mechanisms regulating renin release. Physiol Rev 1976; 56: 1–56.
  • Vander AJ. Control of renin release. Physiol Rev 1967; 47: 359–82.
  • Vander AJ, Miller R. Control of renin secretion in the dog. Am J Physiol 1964; 207: 537–42.
  • Torretti J. Sympathetic control of renin release. Ann Rev Pharmacol Toxicol 1982; 22: 167–92.
  • Osborn it, Thames MD, DiBona GF. Renal nerves moderate renin secretion during autoregulation. Proc Soc Exp Biol Med 1982; 169: 432–7.
  • Kaplan N, Baffler FC. The effect of ACTH, renin, angiotensin II, and various precursors on biosynthesis of aldosterone by adrenal slices. J Clin Invest 1962; 41: 715–25.
  • Burnett JC, Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984; 247: F863–6.
  • Patrono C, Pugliese F, Ciabattoni G, et al. Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest 1982; 69: 231–9.
  • Henrich WL. Role of prostaglandins in renin secretion. Kidney Int 1981; 19: 822–30.
  • Liu FY, Cogan MG. Angiotensin II stimulation of hydrogen ion secretion in rat early proximal tubule. J Clin Invest 1988; 82: 601–7.
  • Shuster VL. Effects of angiotensin on proximal tubular reabsorption. Fed Proc Fed Am Soc Exp Biol 1986; 45: 1444–7.
  • Hall JE, Guyton AC, Smith Jr MJ, Coleman G. Long-term regulation of arterial pressure, glomerular filtra-tion and renal sodium reabsorption by angiotensin II in dogs. Clin Sci 1980; 59: 87S.
  • Hall JE. Control of sodium excretion by angiotensin II: Intrarenal mechanism and blood pressure regulation. Am J Physiol 1986; 250: R960–72.
  • MizeIle HL, Hall JE, Woods LL. Interactions between angiotensin II and renal nerves during chronic sodium deprivation. Am J Physiol 1988; 255: F823–7.
  • Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 1983; 244: F526–34.
  • Ganten D, Stock G. Humoral and neurohormonal aspects of blood pressure regulation: focus on angio-tensin. Klin Wchnschr 1978; 56 (suppl 1): 31–41.
  • Fitzsimons JT. Angiotensin stimulation of the central nervous system. Rev Physiol Biochem Pharmacol 1980; 87: 117–67.
  • Unger T, Badoer E, Ganten D, et al. Brain angiotensin: Pathways and pharmacology. Circulation 1988; 77 (Suppl I): 140–54.
  • Joy MD, Lowe RD. Evidence that the area postrema mediates the central cardiovascular response to angio-tensin II. Nature 1970; 228: 1303–4.
  • Hughes J, Roth RH. Evidence that angiotensin enhances transmitter release during sympathetic nerve stimula-tion. Br J Pharmacol 1971; 41: 239–55.
  • Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 1977; 77: 1–124.
  • Frolich JC, Wilson TW, Sweetman BJ, et al. Urinary prostaglandins. Identification and origin. J Clin Invest 1975; 55: 763–70.
  • Schlondorff D. Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins. Am J Med 1986; 81 (Suppl 2B): 1–11.
  • Schwartz GJ, Burg MB. Mineralocorticoid effects on cation transport by cortical collecting ducts in vitro. Am J Physiol 1978; 235: F576–85.
  • Linde R, Winn S, Latta D, Hollifield J. Graded dose effects of angiotensin II on aldosterone production in man during various levels of potassium intake. Clin Exp Med 1981; 30: 549–53.
  • Hierholzer K, Lange S. The effects of adrenal steroids on renal function. MTP International Review of Science Physiology. Baltimore: University Park Press, 1974; 6: 273–???.
  • Halperin ML, Skorecki KL. Interpretation of the urine electrolytes and osmolality in the regulation of body fluid tonicity. Am J Nephrol 1986; 6: 241–5.
  • Hall JE, Granger JP, Smith Jr MJ, Premen AJ. Role of renal hemodynamics in arterial pressure and aldoster-one escape. Hypertension 1984; 6 (Suppl 1): 1183–92.
  • Shenker Y, Sider RS, Ostafin EA, Grekin RJ. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985; 76: 1684–7.
  • Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191–5.
  • Davis AL. Atrial natriuretic factor. Adv Pediatr 1989; 36: 137–59.
  • Blaine EH. Atrial natriuretic factor plays a significant role in body fluid homeostasis. Hypertension 1990; 15 (1): 2–8.
  • Cogan MG. Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtra-tion. Am J Physiol 1986; 250: F710–4.
  • Sonnenberg H, Honrath U, Chong CK, Wilson DR. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 1986; 250: F963–6.
  • Light DB, Schwiebert EM, Karlson KH, Stanton BA. Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 1989; 243: 383–5.
  • Henrich WL, McAllister EA, Smith PB, et al. Direct inhibitory effect of atriopeptin III on renin release in primate kidney. Life Sci 1987; 41: 259–64.
  • Kudo T, Baird A. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature 1984; 312: 756–7.
  • Franco-Saenz R, Atarashi K, Takagi M, Takagi M, Mulrow PJ. Effect of atrial natriuretic factor on renin and aldosterone. J Cardiovase Pharmacol 1989; 13 (suppl 6): S31–5.
  • Anderson RJ, Dillingham MA. Atrial natriuretic factor inhibition of arginine vasopressin action in rabbit cortical collecting tubule (abstract). Kidney Int 1986; 29: 328.
  • Cappucio FP, Strazzullo P. Giorgione N, Iacone R, Farinaro E, et al. Renal tubular sodium handling and plasma atrial natriuretic peptide, renin activity and aldosterone in untreated men under normal living conditions. Eur J Clin Invest 1991; 21(1): 40–46.
  • Knepper MA, Lankford SP, Terada Y. Renal tubular actions of ANF. Can J Physiol Pharmacol 1991; 69(10): 1537–45.
  • Allen MJ, Ang VTY, Bennett ED, Jenkins JS. Atrial natriuretic peptide inhibits osmotically-induced argi-nine vasopressin release in man. Clin Sci 1988; 75: 35–39.
  • Richards AM, Ikram H, Yandle TG, et al. Renal, haemodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1985; 1: 545–9.
  • Dillingham M, Anderson R. Inhibition of vasopressin action by atrial natriuretic factor. Science 1986; 231: 1572–3.
  • Donckier J, Anderson JV, Yeo T, Bloom SR. Diurnal rhythm in the plasma concentration of atrial natriuretic peptide. New Engl J Med 1986; 315: 710–11.
  • Leppaluoto J, Ruskoaho H. Atrial natriuretic peptide, renin activity, aldosterone, urine volume and electro-lytes during a 24-h sleep-wake cycle in man. Acta Physiol Scand 1990; 139 (1): 47–53.
  • McCance DR, Roberts G, Sheridan B, McKnight JA, Leslie H, et al. Variations in the plasma concentration of natriuretic factor across 24 hours. Acta Endocrinol (Copenh) 1989; 120: 266–70.
  • Miki K, Shiraki K, Sagawa S, et al. Atrial natriuretic factor during head-out immersion at night. Am J Physiol 1988; 254: R235–41.
  • Quirion R, Dalpe M, DeLean A, et al. Atrial natriuretic factor (ANF) binding sites in brain and related structures. Peptides 1984; 5: 1167–72.
  • Mitchell GAG. The nerve supply of the kidneys. Acta Anat 1950; 10: 1–48.
  • Barajas L, Powers K, Wang P. Innervation of the renal cortical tubules: A quantitative study. Am J Physiol 1984; 247: F50–60.
  • DiBona GF. Neurogenic regulation of renal tubular sodium reabsorption. Am J Physiol 1977; 233 (Renal fluid electrolyte physiol. 2): F73–81.
  • Muller J, Barajas L. Electron microscopic and histo-chemical evidence for a tubular innervation in the renal cortex of the monkey. J Ultrastruct Res 1972; 41: 533–49.
  • Bickerton RK, Buckley JP. Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Exp Biol Med 1961; 106: 834–7.
  • Undesser KP, Hasser EM, Haywood JR, et al. Inter-actions of vasopressin with the area postrema in arterial baroreflex in conscious rabbits. Circ Res 1985; 56: 410–7.
  • Westfall TC. Local regulation of adrenergic neuro-transmission. Physiol Rev 1977; 57: 659–728.
  • Schad H, Seller H. Reduction of renal nerve activity by volume expansion in conscious cats. Pfltigers Arch 1976; 363: 155–9.
  • Miki K, Hayashida Y, Sagawa S, Shiraki K. Renal sympathetic nerve activity and natriuresis during water immersion in conscious dogs. Am J Physiol 1989; 256: R299–305.
  • Kopp U. Neural reflexes of urinary tract origin: role in urine excretion. In: Norgaard JP, Djurhuus JC, Hjälmis K, Hellström A-L, Jorgensen TM, eds. 3rd International Children's Continence Symposium. Sydney, Australia: Wells Medical, 1995: 25–36.
  • Pro snitz EH, DiBona GF. Effect of decreased renal sympathetic nerve activity on renal tubular sodium reabsorption. Am J Physiol 1978; 235 (Renal fluid electrolyte physiol 4): F557–63.
  • LaGrange RG, Sloop CH, Schmid HE. Selective stimulation of renal nerves in the anaesthetised dog. Circulation Res 1973; 33: 704.
  • Slick GL, Aguilera AJ, Zambraski EJ, DiBona GF, Kaloyanides GJ. Renal neuroadrenergic transmission. Am J Physiol 1975; 229: 60–5.
  • Veress AT, Chong CK, Sonnenberg H. Effect of acute unilateral renal denervation on intrarenal haemody-namics and urinary excretion in rats before and during hypovolaemia. Clin Sci 1982; 62: 457–64.
  • Ammons WS, Koyama S, Manning JVV. Neural and vascular interaction in renin response to graded renal nerve stimulation. Am J Physiol 1982; 242: R552–62.
  • Blair ML. Stimulation of renin secretion by alpha-receptor agonists. Am J Physiol 1983; 244: E37–44.
  • McDonald KM, Kuruvila KC, Aisenbrey GA, et al. Effect of alpha-and beta-adrenergic stimulation on renal water excretion and medullary tissue cyclic AMP in intact and diabetes insipidus rats. Kidney Intl 1977; 12: 96–103.
  • Dunham EW, Zimmerman BG. Release of prostaglan-din-like material from dog kidney during nerve stimulation. Am J Physiol 1970; 219: 1279–85.
  • Osborn JL, Holdaas H, Thames MD, DiBona GF. Renal adrenoreceptor mediation of antinatriuretic and renin secretion response to low-frequency renal nerve stimu-lation in the dog. Circ Res 1983; 53: 298–305.
  • Schiebinger RJ. Mechanism of inhibition by methacho-line of norepinephrine-stimulated ANP secretion. Am J Physiol 1988; 255: F1429–33.
  • DiBona G. Neural control of renal tubular solute and water transport. Mineral Electrolyte Metab 1989; 15: 44–50.
  • Levenson DJ, Simmons CE, Brenner BM. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med 1982; 72: 354–74.
  • Gerber JG, Nies AS, Olsen RD. Control of canine renin release: macula densa requires prostaglandin synthesis. J Physiol 1981; 319: 419–29.
  • Berl T, Heinrich WL, Erickson AL, et al. Prostaglan-dins in the beta-adrenergic and baroreceptor-mediated secretion of renin. Am J Physiol 1979; 236: F472–7.
  • Seyberth HW, Rascher W, Hackenthal R, et al. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birthweight infants with symptomatic patent ductus arteriosus. J Pediatr 1983; 103: 979–84.
  • Pfeilschifter J, Kurtz A, Bauer C. Role of phospholipase C and protein kinase C in vasoconstrictor-induced prostaglandin synthesis in cultured renal mesangial cells. Biochem J 1986; 234: 125–30.
  • Stahl RA, Paravicini M, Schollmeyer P. Angiotensin II stimulation of prostaglandin E2 and 6-keto-F1a-forma-lion by isolated human glomeruli. Kidney Int 1984; 26: 30–4.
  • Yared A, Kon V. Ichikawa I. Mechanisms of preserva-tion of glomerular perfusion and filtration during acute extracellular fluid volume depletion. J Clin Invest 1985; 75: 1477–87.
  • Gross PA, Schrier RW, Anderson RJ. Prostaglandins and water metabolism: a review with emphasis on in vivo studies. Kidney Int 1981; 19: 839–50.
  • Nadler SP, Herbert SC, Brenner BM. PGE2, forskolin, and cholera toxin interactions in rabbit cortical collect-ing tubule. Am J Physiol 1986; 250: F127–35.
  • Webster ME, Gilmore JP. Influence of kallidin-10 on renal function. Am J Physiol 1964; 206: F56–61.
  • Barraclough MA, Mills IH. Effect of bradykinin on renal function. Clin Sci 1965; 28: 69–78.
  • Shuster VL, Kokko JP, Jacobson HR. Interactions of lyso-bradykinin and anti-diuretic hormone in the rabbit cortical collecting tubule. J Clin Invest 1984; 73: 1659–
  • Thorup C, Persson AEG. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechan-ism. Am J Physiol 1994; 267 (4 Pt 2): F606–11.
  • Ledderhos C, Quies W, Schuster R, Peters R. Renal hemodynamics and excretory function of healthy young men during stimulation of their peripheral arterial chemoreceptors by almitrine bismesylate. Biomed Biochim Acta 1987; 46: 1035–42.
  • Rodenstein DO, d'Odemont JP, Pieters T, Aubert-Tulkens G. Diurnal and nocturnal diuresis and natriur-esis in obstructive sleep apnea. Effects of nasal continuous positive airway pressure therapy. Am Rev Respir Dis 1992; 145 (6): 1367–71.
  • Koopman MG, Koomen GCM, Krediet RT, de Moor EAM, Hoek FJ, Arisz L. Circadian rhythm of glo-merular filtration rate in normal individuals. Clin Sci 1989; 77: 105–11.
  • Cowley AWJ. Vasopressin and cardiovascular regula-tion. Int Rev Physiol 1982; 26: 189–242.
  • Hays RM. Agents affecting the renal conservation of water. In: Gilman AC, Goodman LS, Rall TW, Murad F, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan, 1985: 909–13.
  • Riddell DC, Mallonee R, Phillips JA, Parks JS, Sexton LA. Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin-II and growth hormone releasing factor. Somat Cell Mol Genet 1985; 11: 189.
  • Ivell R, Schmale H, Richter D. Vasopressin and oxytocin precursors as model preprohormones. Neu-roendocrinology 1983; 37 (3): 235–40.
  • Brownstein MJ, Russell JT, Gainer H. Synthesis, transport and release of posterior pituitary hormones. Science 1980; 207: 373–8.
  • Jard S. Vasopressin receptors. Front Horm Res 1985; 13: 89–104.
  • Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992; 357: 333–5.
  • Jard S, Bockaert J. Stimulus-response coupling in neurohypophyseal peptide target cells. Physiol Rev 1975; 55: 489–536.
  • Nielsen S, Chou C-L, Marples D, Christensen El, Kishore BK, Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 1995; 92: 1013–7.
  • Knepper MA, Inoue T. Regulation of aquaporin-2 water channel trafficking by vasopressin. Curr Opin Cell Biol 1997; 9 (4): 560–4.
  • Kishore BK, Terris JM, Knepper MA. Quantitation of aquaporin-2 abundance in microdissected collecting ducts: Axial distribution and control by AVP. Am J Physiol 1996; 271 (1 Pt 2): F62–70.
  • Martin PY, Schrier RW. Role of aquaporin-2 water channels in urinary concentration and dilution defects. Kidney Int Suppl 1998; 65: S57–62.
  • Edwards RM, Trizna W, Kinter LB. Renal microvas-cular effects of vasopressin and vasopressin antago-nists. Am J Physiol 1989; 256: F274–8.
  • Vallotton MB. The multiple faces of the vasopressin receptors. Mol Cell Endocrinol 1991; 78 (1-2): C73–6.
  • Saito M, Sugimoto T, Tahara A, Kawashima H. Molecular cloning and characterization of rat Vlb vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem Biophys Res Commun 1995; 212 (3): 751–7.
  • Grazzini E, Lodboerer AM, Perez-Martin A, Joubert D, Guillon G. Molecular and functional characterization of Vlb vasopressin receptor in rat adrenal medulla. Endocrinology 1996; 137 (9): 3906–14.
  • Ang VTY, Jenkins JS. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycina-mide arginine-vasopressin in the dog. J Endocrinol 1982; 93: 319–25.
  • Buijs RM. Vasopressin and oxytocin - their role in neurotransmission. Pharmacol Ther 1983; 22: 127–41.
  • Landgraf R. Central release of vasopressin: stimuli, dynamics, consequences. Prog Brain Res 1992; 91: 29–39.
  • Manning M, Sawyer WH. Design and uses of selective agonistic and antagonistic analogs of the neuropeptides oxytocin and vasopressin. Trends Neurosci 1984; 7: 6–8.
  • de Wied D, Van Wimersma Greidanus TB, Bohus B, Urban IB, Gispen WH. Vasopressin and memory consolidation. Prog Brain Res 1976; 45: 181–94.
  • Gash DM, Thomas GJ. What is the importance of vasopressin in memory processes? Trends Neurosci 1983; 6: 197–8.
  • Legros JJ, Gilot P. Seron X, et al. Influence of vaso-pressin on learning and memory. Lancet 1978; 1: 41–2.
  • Elands J, de Kloet ER, de Wied D. Neurohypophyseal hormone receptors: relation to behavior. Prog Brain Res 1992; 91: 459–64.
  • Born J, Kellner C, Uthgenannt D, Kern W, Fehm HL. Vasopressin regulates human sleep by reducing rapid-eye-movement sleep. Am J Physiol 1992; 262 (3 Pt 1): E295–300.
  • Fehm-Wolfsdorf G, Born J, Voigt J, Fehm HL. Beha-vioural effects of vasopressin. Neurobiology 1984; 11: 49–53.
  • Schwartz WJ, Reppert SJ. Neural regulation of the circadian vasopressin rhythm in cerebrospinal fluid: A pre-eminent role for the suprachiasmatic nuclei. Journal of Neuroscience 1985; 5 (10): 2771–8.
  • Robertson GL, Shelton RL, Athar S. The osmoregula-tion of vasopressin. Kidney International 1976; 10: 25–37.
  • Zimmerman EA, Ma L-Y, Nilaver G. Anatomical basis of thirst and vasopressin secretion. Kidney International 1987; 32 (Suppl 21): 514–19.
  • Robertson GL. The regulation of vasopressin function in health and disease. Recent Prog Horm Res 1977; 33: 333–85.
  • Zerbe RL. Genetic factors in normal and abnormal regulation of vasopressin secretion. In: Schrier RW, ed. Vasopressin. New York: Raven Press, 1985: 213–20.
  • Thompson CJ, Bland J, Burd J, Baylis PH. The osmotic thresholds for thirst and vasopressin release are similar in healthy man. Clin Sci 1986; 71: 651–6.
  • Thrasher TN. Role of forebrain circumventricular organs in body fluid balance. Acta Physiol Scand 1989; 136 (Suppl 583): 141–50.
  • Robertson GL, Athar S. The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab 1976; 42: 613–20.
  • Davies R, Slater JDH, Forsling ML, Payne N. The response of arginine vasopressin and plasma renin to postural change in normal man, with observations on syncope. Clin Sci Mol Med 1976; 51: 267–274.
  • Quail AW, Woods RL, Korner PI. Cardiac and arterial baroreceptor influences in release of vasopressin and renin during hemorrhage. Am J Physiol 1987; 252: H1120–6.
  • Rascher W, Rauh W, Brandeis WE, Huber K-H, Schärer K. Determinants of Plasma AVP in Children. Acta Pwdiatr Scand 1986; 75: 111–7.
  • Geelen GL, Keil LC, Kravik SE, Wade CE, Thrasher TN, Barnes PR, Pyka G, Nesvig C, Greenleaf GE. Inhibition of plasma vasopressin after drinking in dehydrated humans. Am J Physiol 1984; 247: R968–71.
  • Salata RA, Verbalis JG, Robinson AG. Cold water stimulation of oropharyngeal receptors in man inhibits release of vasopressin. J Clin Endocrinol Metab 1987; 65: 561–7.
  • Thompson CJ, Edwards CRW, Baylis PH. Osmotic and non-osmotic regulation of thirst and vasopressin secre-tion in patients with compulsive water drinking. Clin Endocrinol 1991; 35: 221–8.
  • Gerstberger R, Schutz H, Luther-Dyroff D, Keil R, Simon E. Inhibition of vasopressin and aldosterone release by atrial natriuretic peptide in conscious rabbits. Exp Physiol 1992; 77 (4): 587–600.
  • Burrell LM, Lambert HJ, Baylis PH. Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans. Am J Physiol 1991; 260 (3 Pt 2): R475–9.
  • Eiskjaer H, Pedersen EB. Dose-response study of atrial natriuretic peptide bolus injection in healthy man. Eur J Clin Invest 1993; 23 (1): 37.
  • Thrasher TN, Ramsay DJ. Interactions between vaso-pressin and atrial natriuretic peptides. Ann N Y Acad Sci 1993; 689: 426–37.
  • Weiss NM, Robertson GL. Effect of hypercalcemia and lithium therapy on the osmoregulation of thirst and vasopressin secretion. In: Schrier RW, ed. Vasopressin. New York: Raven Press, 1985: 281.
  • Gold PW, Robertson GL, Post RM, Kaye W, Ballenger J, Rubinow D, Goodwin FK. The effect of lithium on the osmoregulation of arginine vasopressin secretion. J Clin Endocrinol Metab 1983; 56: 295–9.
  • Eisenhoffer G, Johnson RH. Effect of ethanol ingestion on plasma vasopressin and water balance in humans. Am J Physiol 1982; 242: R522–7.
  • Gold PW, Robertson GL, Ballenger JC, Kaye W, Chen J, Rubinow DR, Goodwin FK, Post RM. Carbamaze-pine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab 1983; 57: 952–7.
  • Kamoi K, Robertson GL. Opiates and vasopressin secretion. In: Schrier RW, ed. Vasopressin. New York: Raven Press, 1985: 259.
  • Reid IA, Nolan PL, Wolfe JA, Keil LC. Suppression of vasopressin secretion by clonidine: Effect of adreno-receptor antagonists. Endocrinology 1979; 104: 1403–6.
  • Kawauchi A, Watanabe H, Kitamori T, Imada N, Ohne T. The possibility of centripetal stimulation from the urinary bladder for vasopressin excretion. J Kyoto Pref Univ Med 1993; 102: 747–52.
  • Schaumburg HL, Hunsballe JM, Rittig S, Schmidt F, Pedersen EB, Djurhuus JC. The effect of the full bladder on vasopressin secretion in healthy young adults. Scand J Urol Nephrol 1997; 31 (Suppl 183): 29–30.
  • Schrier RW, Berl T. Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J Clin Invest 1972; 51: 2613–20.
  • Schrier RW, Berl T, Harbottle JA, MacDonald KM. Catecholamines and water excretion. Nephron 1975; 15: 186–96.
  • Renaud LP, Day TA, Randle JCR, Bourque CW. In vivo and in vitro electrophysiological evidence that central noradrenergic pathways enhance the activity of hypothalamic vasopressinergic neurosecretory cells. In: Schrier RW, ed. Vasopressin. New York: Raven Press, 1985: 385–93.
  • Miller TR, Handelman WA, Arnold PE, McDonald KM, Malinoff PB, Schrier RW. Effect of central cate-cholamine depletion on the osmotic and non-osmotic stimulation of vasopressin (antidiuretic hormone) in the rat. J Clin Invest 1979; 64: 1599–1607.
  • Nadal M. Secretory rhythm of vasopressin in healthy subjects with inversed sleep-wake cycle: evidence for the existence of an intrinsic regulation. Eur J Endo-crinol 1996; 134 (2): 174–6.
  • Aschoff J. Circadian rhythms in man: a self-sustained oscillator with an inherent frequency underlies 24-hour periodicity. Science 1965; 148: 1427–32.
  • Moore-Ede MC. Physiology of the circadian timing system: predictive vs reactive homeostasis. Am J Physiol 1986; 250: 737–52.
  • Rubin RT, Poland RE, Ravessoud F, Gouin PR, Tower BB. Antidiuretic hormone: episodic nocturnal secretion in adult men. Endocr Res Comm 1975; 2: 459–69.
  • Weitzman RE, Fisher DA, DiStefano III JJ, Bennett CM. Episodic secretion of arginine vasopressin. Am J Physiol 1977; 233 (1): E32–6.
  • George CPL, Messerle FH, Genest J, Nowaczynski W, Boucher R, Kuchel Orofo-Oftega M. Diurnal variation of plasma-vasopressin in man. J Clin Endocrinol Metab 1975; 41: 332.
  • Hunsballe JM, Hansen TK, Rittig S, Pedersen EB, Djurhuus JC. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis. Clin Endocrinology 1998; 49 (6): 793–801.
  • Helderman JH, Vestal RE, Rowe JVV, Tobin JD, Andres R, Robertson GL. The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: The impact of aging. J Gerontology 1978; 33: 39–47.
  • Andersson KF, Bengtsson B, Paulsen O. Desamino-8-D-arginine vasopressin (dDAVP): Pharmacology and clinical use. Drugs Today 1988; 24: 509–28.
  • Huguenin RL, Sturmer E, Boissonnas RA, Berde B. deamino-arginine-vasopressin, an analogue of arginine vasopressin with high antidiuretic activity. Experientia 1965; 21: 68–9.
  • Saito M, Tahara A, Sugimoto T. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on Vlb vasopressin receptor. Biochem Pharmacol 1997; 53: 1711–17.
  • Robinson AG, Verbalis JG. Treatment of central diabetes insipidus. Front Horm Res 1985; 13: 292–303.
  • Aronson AS, Svenningsen NW. DDAVP test for esti-mation of renal concentrating capacity in infants and children. Arch Dis Childh 1974; 49: 654–9.
  • Schulman S. DDAVP - the multipotent drug in patients with coagulopathies. Transfusion Medicine Reviews 1991; 5 (2): 132–44.
  • Beckwith BE, Petros T, Kanaan-Beckwith S, Couk DI, Haug RJ. Vasopressin analog (DDAVP) facilitates concept learning in human males. Peptides 1982; 3: 627–30.
  • Beckwith BE, Petros TV, Bergloff PJ, Staebler RJ. Vasopressin analog (DDAVP) facilitates recall of narrative prose. Behav Neurosci 1987; 101: 429–32.
  • Hjälm5s K. Urodynamics in normal infants and children. Scand J Urol Nephrol 1988; (Suppl 114): 20–27.
  • Norgaard JP, van Gool JD, Hjälmis K, Djurhuus JC, Hellström A-L. Standardization and definitions in lower urinary tract dysfunction in children. Br J Urol 1998; 81 (Suppl 3): 1–16.
  • El-Badawi A, Schenk EA. Dual innervation of the mammalian urinary bladder. A histochemical study of the distribution of cholinergic and adrenergic nerves. Amer J Anat 1966; 119: 405–16.
  • Kuru M. Nervous control of micturition. Physiol Rev 1965; 45: 425–94.
  • de Groat WC. Nervous control of the urinary bladder in the cat. Brain Res 1975; 87: 201–11.
  • Nergirdh A, Boréus LO. Autonomic receptor function in the lower urinary tract of man and cat. Scand J Urol Nephrol 1972; 6: 32–6.
  • Saum WR, DeGroat WC. Parasympathetic ganglia: activation of an adrenergic inhibitory mechanism by cholinomimetic agents. Science 1972; 175: 659–61.
  • de Groat WC, Booth AM. Physiology of the urinary bladder and urethra. Ann Intern Med 1980; 92 (Pt 2): 312–5.
  • Barrington FJF. The relation of hindbrain to micturi-tion. Brain 1921; 44: 23–53.
  • Tang PC, Ruch TC. Localization of brain stem and diencephalic areas controlling the micturition reflex. J Comp Neurol 1956; 71: 437–55.
  • Bradley WE, Conway CJ. Bladder representation in the pontine-mesencephalic reticular formation. Exp Neurol 1966; 16: 237–49.
  • Yoshimura N, Sasa M, Ohna Y, Yoshida O, Takaori S. Contraction of urinary bladder by central norepine-phrine originating in the locus coeruleus. J Urol 1988; 139: 423–7.
  • Noto H, Roppolo JR, Steers WD, de Groat WC. Excitatory and inhibitory influences on bladder activity elicited by electrical stimulation in the pontine micturition center in the rat. Brain Res 1989; 17 (492 (1–2)): 99–115.
  • Morrison JFB. Bladder Control: Role of Higher Levels of the Central Nervous System. In: Torrens M, Morrison JFB, eds. The Physiology of the Lower Urinary Tract. London, Berlin etc: Springer-Verlag, 1987: 217–74.
  • Fletcher TF, Bradley WE. Neuroanatomy of the bladder-urethra. J. Urol. 1978; 119: 153–60.
  • Raz S, Zeigler M, Caine M. Isometric studies on canine urethral musculature. Invest Urol 1972; 9: 443–6.
  • de Groat WC, Laney PM. Reflex firing in the lumbar sympathetic outflow to activation of vesical afferent fibers. J Physiol 1972; 226: 289–309.
  • Blok BF, de Weerd H, Holstege G. The pontine micturition center projects to sacral cord GABA immunoreactive neurons in the cat. Neurosci Lett 1997; 233 (2-3): 109–12.
  • Tanagho EA, Miller ER. Initiation of voiding. Br J Urol 1970; 42: 175–83.
  • Jonas U, Tanagho EA. Studies on vesicourethral reflexes. I. Urethral sphincteric responses to detrusor stretch. Invest Urol 1975; 12: 357–73.
  • Holstege G, Griffiths D, De Wall H, Dalm E. Anatomical and physiological observations on suprasp-inal control of bladder and urethral sphincter muscles in the cat. J Comp Neurol 1986; 250: 449–61.
  • de Groat WC. Anatomy and physiology of the lower urinary tract. Urol Clin North Am 1993; 20 (3): 383–401.
  • Jung SY, Fraser MO, Ozawa H, Yokohama O, Yoshiyama M, De Groat WC, Chancellor MB. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incon-tinence and detrusor instability. J Urol 1999; 162 (1): 204–12.
  • de Groat WC. Anatomy of the central neural pathways controlling the lower urinary tract. Eur Urol 1998; 34 (Suppl 1): 2–5.
  • Mevorach RA, Kogan BA. Fetal lower urinary tract physiology: in vivo studies. Adv Exp Med Biol 1995; 385: 385–91, discussion 131-9.
  • Ohel G, Haddad S, Samueloff A. Fetal urine production and micturition and fetal behavioral state. Am J Perinatol 1995; 12 (2): 91–2.
  • Wlodek ME, Thorbum GD, Harding R. Bladder con-tractions and micturition in fetal sheep: their relation to behavioral states. Am J Physiol 1989; 257 (6 Pt 2): R1526–32.
  • Zimmer EZ, Chao CR, Guy GP, Marks F, Fifer WP. Vibroacoustic stimulation evokes human fetal micturi-tion. Obstet Gynecol 1993; 81(2): 178–80.
  • Sugaya K, Roppolo JR, Yoshimura N, Card JP, de Groat WC. The central neural pathways involved in micturition in the neonatal rat as revealed by the injection of pseudorabies virus into the urinary bladder. Neurosci Lett 1997; 223 (3): 197–200.
  • Araki I, de Groat WC. Developmental synaptic depression underlying reorganization of visceral reflex pathways in the spinal cord. J Neurosci 1997; 17: 8402–7.
  • Hjälmas K. Micturition in infants and children with normal lower urinary tract. Scand J Urol Nephrol 1976; (Suppl 37).
  • Yeung CK, Godley ML, Ho CKW, Duffy PG, Ransley RG, Chen CN, Li AKC. Some new insights into bladder function in infancy. Br J Urol 1995; 76: 235–40.
  • Gierup J. Micturition studies in infants and children. Scand J Urol Nephrol 1970; 4: 217–30.
  • Hellström A-L, Hansson E, Hansson S, Hjälmas K, Jodal U. Incontinence and micturition habits in 7-year-old Swedish school entrants. Eur J Pediatr 1990; 149: 434–7.
  • Hansen A, Hansen B, Dahm TL. Urinary tract infection, day wetting and other voiding symptoms in seven-to eight-year-old Danish children. Acta Pwdiatr 1997; 86: 1345–9.
  • Bloom DA, Seeley WW, Ritchey ML, McGuire EJ. Toilet habits and incontinence in children: an opportu-nity sampling in search of normal parameters. J Urol 1993; 149: 1087–90.
  • Bower WF, Moore KH, Shepherd RB, Adams RD. The epidemiology of childhood enuresis in Australia. Br J Urol 1996; 78 (4): 602–6.
  • Nevéus T, Hetta J, Cnattingius S, Tuvemo T, Läckgren G, Olsson U, Stenberg A. Depth of sleep and sleep habits among enuretic and incontinent children. Acta Paediatr 1999; 88: 748–52.
  • Cistemino A, Passerini-Glazel G. Bladder dysfunction in children. Scand J Urol Nephrol 1995; (Suppl 173): 25–29.
  • Bauer SB, Retik AB, Colodny AH, Hallett M, Khoshbin S, Dyro FM. The unstable bladder of childhood. Urol Clin North Am 1980; 7: 321–36.
  • Low A. Urethral behavior during the involuntary detrusor contraction. Am J Obstet Gynecol 1977; 128 (1): 32–42.
  • Blaivas JG. The neurophysiology of micturition: a clinical study of 550 patients. J Urol 1982; 127 (5): 958–63.
  • Rechtschaffen A, Kales AA. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute, 1968.
  • Vaughn By, Quint SR, Messenheimer JA, Robertson KR. Heart period variability during sleep. Electroence-phalogr Clin Neurophysiol 1995; 94 (3): 155–62.
  • Baharav A, Kotagal S, Gibbons V, Rubin BK, Pratt G, Karin J, Akselrod S. Fluctuations in autonomic activity during sleep displayed by power spectrum analysis of heart rate variability. Neurology 1995; 45 (6): 1183–7.
  • Bonnet MH, Arand DL. Heart rate variability: sleep stage, time of night, and arousal influences. Electro-encephalogr Clin Neurophysiol 1997; 102 (5): 390–6.
  • Zemaityte D, Varoneckas G, Sokolov E. Heart rhythm control during sleep. Psychophysiology 1984; 21: 279–89.
  • Pivik RT, Busby KA, Gill E, Hunter P, Nevins R. Heart rate variations during sleep in preadolescents. Sleep 1996; 19 (2): 117–35.
  • McCarley RW. REM dreams, REM sleep, and their isomorphisms. In: Chase M, Weitzman ED, eds. Sleep Disorders: Basic and Clinical Research. New York: Spectrum Publications, 1983: 363–92.
  • Aserinsky E, Kleitman N. Regularly occurring periods of eye motility and concurrent phenomena during sleep. Science 1953; 118: 273–4.
  • Jouvet M, Michel F, Courjon J. Sur un stade d'activité dectrique cérébrale rapide au cours du sommeil physiologique. C R Soc Biol (Paris) 1959; 153: 1024–28.
  • Takakusaki K, Ohta Y, Mori S. Single medullary reticulospinal neurons exert postsynaptic inhibitory effects via inhibitory intemeurons upon alpha-moto-neurons innervating cat hindlimb muscle. Exp Brain Res 1989; 74: 11–23.
  • Cajochen C, Pischke J, Aeschbach D, Borbély AA. Heart rate dynamics during human sleep. Physiol Behav 1994; 55 (4): 769–74.
  • Berthon-Jones M, Sullivan CE. Ventilatory and arousal responses to hypoxia in sleeping humans. Am Rev Respir Dis 1982; 125: 632–9.
  • Douglas NJ, White DP, Weil JV, Pickett CK, Zwillich CW. Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis 1982; 126: 758–62.
  • Duron B, Tassinari CA, Gastaut H. Analyse spirogra-phique et dectromyographique de la respiration au cours du sommeil contr616 par l'EEG chez l'homme normal. Rev Neurol 1966; 115: 562–74.
  • Buguet AG, Livingstone SD, Reed LD. Skin tempera-ture changes in paradoxical sleep in man in the cold. Aviat Space Environ Med 1979; 50: 567–70.
  • Shapiro CM, Moore AT, Mitchell D, Yodaiken ML. How well does man thermoregulate during sleep? Experientia 1974; 30: 1279–81.
  • Scholz UJ, Bianchi AM, Cerutti S, Kubicki S. Vegetative background of sleep: spectral analysis of the heart rate variability. Physiol Behav 1997; 62 (5): 1037–43.
  • Fisher C, Gross J, Zuch J. Cycle of penile erection synchronous with dreaming (REM) sleep: Preliminary report. Arch Gen Psychiatry 1965; 12: 29–45.
  • Greenberg R, Perlman C. Cutting a REM nerve: An approach to the adaptive role of REM sleep. Perspect Biol Med 1974; 17: 513.
  • Crick F, Mitchison G. The function of dream sleep. Nature 1983; 304: 111–4.
  • Parmeggiani PL. The autonomic nervous system during sleep. In: Kryger MH, Roth T, Dement WC., eds. Principles and practice of sleep medicine. Philadel-phia: W. B. Saunders, 1994: 194–203.
  • Steriade M, Iosif G, Apostol A. Responsiveness of thalamic and cortical motor relays during arousal and various stages of sleep. J Neurophysiol 1969; 32: 251–65.
  • Carskadon MA, Dement WC. Normal Human Sleep: An Overview. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 2nd ed. Philadelphia: W. B. Saunders, 1994: 17–25.
  • Nicolas A, Dewasmes G, Erhart J, Muzet AG. Physiological variation of transient activation phases (TAP) during human sleep. J Sleep Res 1996; 5 (Suppl): 155.
  • Coble PA, Kupfer DJ, Taska LS, Kane J. EEG sleep of normal healthy children. Part I. Findings using standard measurement methods. Sleep 1984; 7: 289–303.
  • Moore RY. The suprachiasmatic nucleus and the organization of a circadian system. Trends Neurosci 1982; 5: 404–7.
  • Czeisler CA, Kronauer RE, Allan JS, et al. Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science 1989; 244: 1328–33.
  • Klein DC, Moore RY. Pineal N-acetyltransferase and hydroxyindole-O-methyl-transferase: Control by the retinohypothalamic tract and the suprachiasmatic nucleus. Brain Res 1979; 174: 245–62.
  • Brown GM. Light, melatonin and the sleep-wake cycle. Journal of Psychiatry & Neuroscience 1994; 19 (5): 345–53.
  • Tapanainen P. Rantala H, Leppaluoto J, Lautala P. Kaar ML, Knip M. Nocturnal release of immunoreactive growth hormone-releasing hormone and growth hor-mone in normal children. Pediatr Res 1989; 26 (5): 404–9.
  • Sassin J, Parker D, Mace J, Gotlin R, Johnson L, Rossman L. Human growth-hormone release - relation to slow wave sleep and sleep-waking cycles. Science 1969; 165: 513.
  • Finkelstein JW, Roffwarg HP, Boyar RM, Kream J, Hellman L. Age related change in twenty-four hour spontaneous secretion of growth hormone. J Clin Endo-crinol Metab 1972; 35: 665–70.
  • Glotzbach SF, Heller HC. Temperature Regulation. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: W. B. Saunders, 1994: 260–75.
  • Parker DC, Pekary AE, Hershman JM. Effect of 64-hour sleep deprivation on the circadian waveform of thyrotropin (TSH): Further evidence of sleep-related inhibition of TSH release. J Clin Endocrinol Metab 1987; 64: 157–61.
  • Waldstreicher J, Duffy JF, Brown EN, Rogacz S, Allan JS, Czeisler CA. Gender differences in the temporal organization of prolactin (PRL) secretion: evidence for a sleep-independent circadian rhythm of circulating PRL levels-a clinical research center study. J Clin Endocrinol Metab 1996; 81(4): 1483–7.
  • Follenius M, Brandenberger G, Saini J. Lack of diurnal rhythm in plasma atrial natriuretic peptide. Life sci 1992; 51(2): 143–9.
  • Buijs RM, Hermes MH, Kalsbeek A. The suprachias-matic nucleus-paraventricular nucleus interactions: a bridge to the neuroendocrine and autonomic nervous system. Prog Brain Res 1998; 119: 365–82.
  • Steiger A, Antonijevic I, Frieboes R-M, Murck H, Schier T. The role of GHRH in normal and pathological sleep regulation. International Symposium Growth Hormone and Growth Factors in Endocrinology and Metabolism. Vienna, 1996: 106.
  • Kerkhofs M, van Cauter E, Thomer MO, Copinschi G. Growth hormone (GH), GH-releasing hormone (GIIRH), GH-releasing peptide (GHRP) and sleep in man. J Sleep Res 1996; 5 (Suppl 1): 107.
  • Born J, De Kloet ER, Wenz H, Kern W, Fehm HE. Gluco-and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 1991; 260 (Endocrinol Metab 23): E183–8.
  • Robbins TW, Granon S, Muir it, Durantou F, Harrison A, Everitt BJ. Neural systems underlying arousal and attention. Implications for drug abuse. Ann N Y Acad Sci 1998; 846: 222–237.
  • Coull JT. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroima-ging and psychopharmacology. Prog Neurobiol 1998; 55 (4): 343–61.
  • Steriade M. Arousal: revisiting the reticular activating system. Science 1996; 272 (5259): 225–6.
  • Starzl TE, Taylor CW, Magoun HW. Collateral afferent excitation of reticular formation of brain stem. J Neurophysiol 1951; 14: 479–96.
  • Moruzzi G, Magoun HW. Brain stem reticular forma-tion and activation of the EEG. 1949. Electroencepha-logr Clin Neurophysiol 1949; 1: 455–73.
  • Kitsikis A, Steriade M. Immediate behavioral effects of kainic acid injections into the midbrain reticular core. Behav Brain Res 1981; 3: 361–80.
  • Lindsley DV, Schreiner LH, Knowles WB, Magoun HW. Behavioral and EEG changes following chronic brain stem lesions in the cat. EEG Clin Neurophysiol 1950; 2: 483–98.
  • Svensson TH. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in the brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology (Berl) 1987; 92 (1): 1–7.
  • Foote SL, Freedman R, Oliver AP. Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res 1975; 86: 229–42.
  • Segal M, Bloom FE. The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity. Brain res 1976; 107: 513–25.
  • Foote SL, Bloom FE, Aston-Jones G. Nucleus locus coeruleus: New evidence of anatomical and physio-logical specificity. Physiol Rev 1983; 63: 844–914.
  • Dienstbier RA. Arousal and physiological toughness: implications for mental and physical health. Psychol Rev 1989; 96: 84–100.
  • Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-wake cycle. J Neurosci 1981; 1: 876–886.
  • Reiner PB. Correlational analysis of central noradre-nergic neuronal activity and sympathetic tone in behaving cats. Brain Res 1986; 378 (1): 86–96.
  • Goadsby PJ. Brainstem activation of the adrenal medulla in the cat. Brain Res 1985; 327 (1-2): 241–8.
  • Drolet G, Gauthier P. Peripheral and central mechan-isms of the pressor response elicited by stimulation of the locus coeruleus in the rat. Can J Physiol Pharmacol 1985; 63 (6): 599–605.
  • Aston-Jones G, Chiang C, Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res 1991; 88: 501–20.
  • Horner RL, Brooks D, Kozar LF, Tse S, Phillipson EA. Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol 1995; 79: 151–62.
  • Horner RE. Autonomic consequences of arousal from sleep: mechanisms and implications. Sleep 1996; 19 (10 Suppl): S193–5.
  • Bradley WE. Cerebro-cortical innervation of the urinary bladder. Tohoku J Exp Med 1980; 131 (1): 7–13.
  • Elam K, Thoren P. Svensson TH. Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents. Brain Res 1986; 375: 117–25.
  • Page ME, Akaoka H, Aston-Jones G, Valentino RJ. Bladder distension activates noradrenergic locus coer-uleus neurons by an excitatory amino acid mechanism. Neuroscience 1992; 51: 555–63.
  • Page ME, Valentino RJ. Locus coeruleus activation by physiological challenges. Brain Res Bull 1994; 35 (5-6): 557–60.
  • Rechtschaffen A, Hauri P. Zeitlin M. Auditory awakening thresholds in REM and NREM sleep stages. Percept Mot Skills 1966; 22: 927.
  • Lammers WJ, Badia P. Motor responsiveness to stimuli presented during sleep: the influence of time-of-testing on sleep stage analyses. Physiology and Behavior 1991; 50: 867–8.
  • Williams HL, Hammack JT, Daly RL, Dement WC, Lubin A. Responses to auditory stimulation, sleep loss and the EEG stages of sleep. Electroencephalogr Clin Neurophysiol 1964; 16: 269–79.
  • Candas V, Libert JP, Muzet A. Heating and cooling stimulations during SWS and REM sleep in man. J Therm Biol 1982; 7: 155–8.
  • Keefe FB, Johnson LC, Hunter EJ. EEG and autonomic response pattern during waking and sleep stages. Psychophysiology 1971; 8: 198–212.
  • Chugh DK, Weaver TE, Dinges DF. Neurobehavioral consequences of arousals. Sleep 1996; 19 (10 Suppl): S198–201.
  • Bonnet MH, Johnson LC. Relationship of arousal threshold to sleep stage distribution and subjective estimates of depth and quality of sleep. Sleep 1978; 1: 161–8.
  • Busby KA, Mercier L, Pivik RT. Ontogenic variations in auditory arousal threshold during sleep. Psychophy-siology 1994; 31: 182–8.
  • Coble PA, Kupfer DJ, Reynolds CF, Houck P. EEG sleep of healthy children 6 to 12 years of age. In: Guilleminault C, ed. Sleep and its disorders in children. New York: Raven Press, 1987: 29–41.
  • Kahn A, Van de Merckt C, Rebuffat E, Mozin MJ, Sottiaux M, Blum D, Hennart P. Sleep problems in healthy preadolescents. Pediatrics 1989; 84: 542–6.
  • Klackenberg G. Sleep behavior studied longitudinally. Data from 4–16 years on duration, night-awakening and bedsharing. Acta Paediatr Scand 1982; 71: 501.
  • Simonds JF, Parraga H. Prevalence of sleep disorders and sleep behavior in children and adolescents. J Am Coll Psychiatry 1982; 25: 75–89.
  • Broughton RJ. Sleep disorders: disorders of arousal? Enuresis, somnambulism, and nightmares in confu-sional states of arousal, not in "dreaming sleep". Science 1968; 159: 1070–78.
  • Hulterantz E, Löfstrand-Tideström B, Ahlquist-Rastad J. The epidemiology of sleep related breathing disorder in children. Int J Pediatr Otorhinolaryngol 1995; 32 (Suppl): S63–6.
  • Teculescu DB, Caillier I, Perrin P. Rebstock E, Rauch A. Snoring in French preschool children. Pediatr Pulmonol 1992; 13 (4): 139–44.
  • Clemente V, Ferreira A, Fernandes C, Allen A, Azevedo MH. Prevalence of snoring in portuguese primary school children. J Sleep Res 1996; 5 (Suppl 1): 35.
  • Ali NJ, Pitson D, Stradling JR. Natural history of snoring and related behaviour problems between the ages of 4 and 7 years. Arch Dis Child 1994; 71(1): 74–6.
  • Owen GO, Canter RJ, Robinson A. Snoring, apnoea and ENT symptoms in the paediatric community. Clin Otolaryngol 1996; 21(2): 130–4.
  • Watanabe H, Azuma Y. A proposal for a classification system of enuresis based on overnight simultaneous monitoring of electroencephalography and cystometry. Sleep 1989; 12: 257–64.
  • Arena F, Romeo C, Manganaro A, Vita PM, Cifala S, Cruccetti A, Romeo G. Rilievi videourodinamici nel bambino con enuresi. Pediatr Med Chir 1996; 18 (5): 515–8.
  • Neveus T. The bladder and the brain. Studies on the pathogenesis and treatment of nocturnal enuresis (Thesis). Uppsala: Uppsala University, 1999: 59.
  • Levine MD. Encopresis: its potentiation, evaluation and alleviation. Pediatr Clin North Am 1982; 29: 315–30.
  • Loening-Baucke V. Toilet tales: stool toileting refusal, encopresis and fecal incontinence. J Wound Ostomy Continence Nurs 1998; 25 (6): 304–13.
  • Marugan de Miguelsanz JM, Lapena Lopez de Armentia S, Rodriguez Fernandez LM, Palau Bena-vides MT, Torres Hinojal MC, Menau Martin G, Gutierrez Fernandez M, Alvaro Iglesias E. Analisis epidemiologico de la secuencia de control vesical y prevalencia de enuresis noctuma en ninos de la provincia de leon. An Esp Pediatr 1996; 44 (6): 561–7.
  • Laberge L, Denesle R, Tremblay R, Montplaisir J. Parasomnias in 2000 children aged 11. J Sleep Res 1996; 5 (Suppl 1): 114.
  • Power C, Manor O. Asthma, enuresis, and chronic illness: long term impact on height. Arch Dis Child 1995; 73: 298–304.
  • van der Wal ME, Pauw-plomp H, Schulpen TW. Bedplassen bij Nederlandse, Surinaamse, Marokkaanse en Turkse kinderen van 3-4,5-6 en 11-12 jaar. Ned Tijdschr Geneeskd 1996; 140 (48): 2410–4.
  • Alon U, Woodward CP, Howard CP. Urine volume, age and nocturnal enuresis: a prospective study on newly diagnosed children with diabetes mellitus. Children's Hospital Quarterly 1992; 4: 157–60.
  • Hirasing RA, van Leerdam FJ, Bolk-Bennink L, Janknegt RA. Enuresis noctuma in adults. Scand J Urol Nephrol 1997; 31(6): 533–6.
  • Forsythe WI, Redmond A. Enuresis and spontaneous cure rate: study of 1129 enuretics. Arch Dis Child 1974; 49: 259–63.
  • Monda JM, Husmann DA. Primary nocturnal enuresis: a comparison among observation, imipramine, desmo-pressin acetate and bed-wetting alarm systems. J Urol 1995; 154 (2 Pt 2): 745–8.
  • Bakwin H. Enuresis in twins. Am J Dis Child 1971; 121: 222–5.
  • Levine A. Enuresis in the Navy. Am J Psychiat 1943; 100: 320–5.
  • Hallgren B. Enuresis: a clinical and genetic study. Acta Psychiatr Neurol Scand 1957; 32 (suppl 114): 27–40.
  • Devlin JB. Prevalence and risk factors for childhood nocturnal enuresis. Ir Med J 1991; 84(4): 118–20.
  • Järvelin MR, Vikeväinen-Tervonen L, Moilanen I, Huttunen N-P. Enuresis in seven-year-old children. Acta Pediatr Scand 1988; 77: 148–53.
  • Robson WLM, Leung AKC, Brant R. The genetic influence in primary nocturnal enuresis. Nocturnal Enuresis 1992; 2 (3): 4–6.
  • Bower WF, Moore KIT, Adams R, Shepherd R. Frequency-volume chart data and family history trends from 322 enuretic children. In: Norgaard JP, Djurhuus JC, Hjälmis K, Hellström A-L, Jorgensen TM, eds. 3rd International Children's Continence Symposium. Sydney, Australia: Wells Medical, 1995.
  • Eiberg H, Berendt I, Mohr J. Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q. Nature Genetics 1995; 10 (July): 354–6.
  • Arnell H, Hjälmis K, Jägervall M, Läckgren G, Stenberg A, Bengtsson B, Wassen C, Emahazion T, Anneren G, Pettersson U, Sundvall M, Dahl N. The genetics of primary nocturnal enuresis; inheritance and suggestion of a second major gene on chromosome 12q. J Med Genet 1997; 34 (5): 360–5.
  • Eiberg H. Total genome scan analysis in a single extended family for primary nocturnal enuresis: evidence for a new locus (ENUR3) for primary nocturnal enuresis on chromosome 22q11. Eur Urology 1998; 33 (suppl 3): 34–6.
  • von Gontard A, Hollmann E, Eiberg H, Benden B, Rittig S, Lehmkuhl G. Clinical enuresis phenotypes in familial nocturnal enuresis. Scand J Urol Nephrol 1997; 31 (Suppl 183): 8–16.
  • Norgaard JP, Pedersen EB, Djurhuus JC. Diurnal anti-diuretic hormone levels in enuretics. J Urol 1985; 134: 1029–31.
  • Rittig S, Knudsen UB, Norgaard JP, Pedersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 1989; 256: F664–71.
  • Aikawa T, Kasahara T, Uchiyama M. The arginine-vasopressin secretion profile of children with primary nocturnal enuresis. Eur Urol 1998; 33 (suppl 3): 41–4.
  • Vurgun N, Yiditodlu MR, Ypean A, An Z, Tarhan S, Scand J Urol Nephrol Suppl 206 Balkan C. Hypematriuria and kaliuresis in enuretic children and the diurnal variation. J Urol 1998; 159 (4): 1333–7.
  • Rasmussen PV, Kirk J, Rittig S. Djurhuus JC. The enuretic episode - a complete micturition from a bladder with normal capacity? A critical reappraisal of the definition. Scand J Urol Nephrol 1997; 31 (Suppl 183): 23–4.
  • Eggert P. Kuhn B. Antidiuretic hormone regulation in patients with primary nocturnal enuresis. Arch Dis Child 1995; 73: 508–11.
  • Steffens J, Netzer M, Isenberg E, Alloussi S, Ziegler M. Vasopressin deficiency in primary nocturnal enuresis. Eur Urol 1993; 24: 366–70.
  • Läckgren G, Nevéus T, Stenberg A. Diurnal plasma vasopressin and urinary output in adolescents with monosymptomatic nocturnal enuresis. Acta Pediatr 1997; 86(4): 385–90.
  • Wille S, Aili M, Harris A, Aronson S. Plasma and urinary levels of vasopressin in enuretic and none-nuretic children. Scand J Urol Nephrol 1994; 28: 119–22.
  • Hunsballe JM, Hansen TK, Rittig S, Norgaard JP, Pedersen EB, Djurhuus JC. Polyuric and non-polyuric bedwetting - pathogenetic differences in nocturnal enuresis. Scand J Urol Nephrol 1995; S173: 77–9.
  • Eggert P. Mtiller-Schluter K, Milner D. Regulation of arginine vasopressin in enuretic children under fluid restriction. Pediatrics 1999; 103: 452–5.
  • Devitt H, Holland P, Butler R, Redfern E, Hiley E, Roberts G. Plasma vasopressin and response to treatment in primary nocturnal enuresis. Arch Dis Child 1999; 80: 448–51.
  • Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol 1995; 26 (6): 1203–9.
  • Watanabe H, Kawauchi A. Nocturnal enuresis: social aspects and treatment perspectives in Japan. Scand J Urol Nephrol 1994; Suppl 163: 29–38.
  • Natochin YV, Kuznetsova AA. Nocturnal enuresis: correction of renal function by desmopressin and diclofenac. Pediatr Nephrol 2000; 14 (1): 42–7.
  • Rittig S, Knudsen UB, Norgaard JP, Gregersen H, Pedersen EB, Djurhuus JC. Diurnal variation of plasma atrial natriuretic peptide in normals and patients with enuresis noctuma. Scand J Clin Lab Invest 1991; 51(2): 209–17.
  • Rittig S, Matthiesen TB, Pedersen EB, Djurhuus JC. Sodium regulating hormones in enuresis. Scand J Urol Nephrol 1999; 33 (Suppl 202): 45–6.
  • Linderholm EB. The cystometric findings in enuresis. J Urol 1966; 96: 718–22.
  • Hindmarsh JR, Byrne PO. Adult enuresis - A sympto-matic and urodynamic assessment. Br J Urol 1980; 52: 88–91.
  • Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol 1999; 162 (3 Pt 2): 1049–54,1054-5.
  • Vulliamy D. The day and night urine output of urine in enuresis. Arch Dis Child 1959; 31: 439.
  • Berger MR, Maizels M, Moran CG, Conway JJ, Firlit FC. Bladder capacity (ounces) equals age (years) plus 2 predicts normal bladder capacity and aids in diagnosis of abnormal voiding patterns. J Urol 1983; 129: 347–9.
  • Hallman N. On the ability of enuretic children to hold urine. Acta Pediatr 1950; 39: 87–93.
  • Starfield B. Functional bladder capacity in enuretic and nonenuretic children. J Pediatr 1967; 70: 777–81.
  • Nevéus T, Läckgren G, Tuvemo T, Stenberg A. Osmoregulation and desmopressin pharmacokinetics in enuretic children. Pediatrics 1999; 103 (1): 65–70.
  • Troup CW, Hodgson NB. Nocturnal functional bladder capacity in enuretic children. J Urol 1971; 105: 129–32.
  • Esperanca M, Gerrard JVV. Nocturnal enuresis: studies in bladder function in normal children and enuretics. Can Med Assoc J 1969; 101:324–7.
  • Otto JC. Cases of congenital incontinence of urine. North American M. & S. J. 1830; 10: 364.
  • Nevéus T, Läckgren G, Tuvemo T, Olsson U, Stenberg A. Desmopressin-resistant enuresis: pathogenetic and therapeutic considerations. J Urol 1999; 162: 2136–40.
  • Bonde HV, Andersen JP, Rosenkilde P. Nocturnal enuresis: Change of nocturnal voiding pattern during alarm treatment. Scand J Urol Nephrol 1994; 28: 349–52.
  • Oredsson AF, Jorgensen TM. Changes in nocturnal bladder capacity during treatment with the bell and pad for monosymptomatic nocturnal enuresis. J Urol 1998; 160 (1): 166–9.
  • Hindmarsh JR, Byrne PO. Is the enuretic female bladder without instability normal? Urol Res 1981; 9 (3): 133–5.
  • Whiteside CG, Arnold EP. Persistent primary enuresis: a urodynamic assessment. Br Med J 1975; 1 (5954): 364–7.
  • Wen JG, Tong EC. Cystometry in infants and children with no apparent voiding symptoms. Br J Urol 1998; 81 (3): 468–73.
  • Bugge-Nielsen J, Norgaard JP, Sorensen SS, Jorgensen TM, Djurhuus JC. Continuous overnight monitoring of bladder activity in vesicoureteral reflux patients: II. Bladder activity types. Neurourol Urodyn 1984; 3: 7–21.
  • Yazbeck S, Schick E, O'Regan S. Relevance of con-stipation to enuresis, urinary tract infection and reflux. A review. Eur Urol 1987; 13 (5): 318–21.
  • Clavero Arevalo M, Toro Trallero J. (Enuresis and encopresis: their relationship) Spanish. An Esp Pediatr 1993; 39 (4): 320–4.
  • Kalo BB, Bella H. Enuresis: prevalence and associated factors among primary school children in Saudi Arabia. Acta Pediatr 1996; 85: 1217–22.
  • Foreman DM, Thambirajah MS. Conduct disorder, enuresis and specific developmental delays in two types of encopresis: a case-note study of 63 boys. Eur Child Adolesc Psychiatry 1996; 5 (1): 33–7.
  • O'Regan S, Yazbeck S, Hamberger B, Schick E. Constipation a commonly unrecognized cause of enur-esis. Am J Dis Child 1986; 140 (3): 260–1.
  • Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics 1997; 100: 228–32.
  • Shopfner CE. Urinary tract pathology associated with constipation. Radiology 1968; 90: 865–77.
  • Brading AP, Turner WH. The unstable bladder: towards a common mechanism. Br J Urol 1994; 73: 3–8.
  • Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol 1998; 160 (3 Pt 2): 1019–22.
  • Trousseau A. Lectures on Clinical Medicine. London: New Sydenham Society, 1870; 3: 475.
  • Wille S. Nocturnal enuresis: sleep disturbance and behavioural patterns. Acta Pediatr 1994; 83: 772–4.
  • Bostock J. Exterior gestation, primitive sleep, enuresis and asthma: A study in aetiology. Med J Aust 1958; 2: 149,185.
  • Klackenberg G. Nocturnal enuresis in a longitudinal perspective. Acta Pediatr Scand 1981; 70: 453–7.
  • Yeung CK. Nocturnal enuresis in Hong Kong: different Chinese phenotypes. Scand J Urol Nephrol 1997; 31 (Suppl 183): 17–21.
  • Nevéus T, Läckgren G, Stenberg A, Tuvemo T, Hetta J. Sleep and night-time behaviour of enuretics and non-enuretics. Br J Urol 1998; 81 (Suppl 3): 67–71.
  • Broughton R, Gastaut H. Polygraphic sleep studies of enuresis nocturna. Electroenceph Clin Neurophysiol 1964; 16: 625–6.
  • Pierce CM, Whitman RM, Maas JW, Gay ML. Enuresis and dreaming. Arch Gen Psychiatry 1961; 4: 166–70.
  • Neal BW. Nocturnal enuresis in children. Aust Fam Physician 1989; 18: 978-9,982–3.
  • Ditman KS, Blinn KA. Sleep levels in enuresis. Amer J Psychiat 1955; 3: 913–20.
  • Evans JI. Sleep of enuretics (letter). Br Med J 1971; 3 (766): 110.
  • Reimao R, Pachelli LC, Cameiro R, Faiwichow G. Primary Sleep Enuresis in Childhood. Polysomno-graphic Evidences of Sleep Stage and Time Modula-tion. Arq Neuropsiquiatr 1993; 51(1): 41–5.
  • Weider DJ, Sateia MJ, West RP. Nocturnal enuresis in children with upper airway obstruction. Otolaryngol Head Neck Surg 1991; 105 (3): 427–32.
  • Nevéus T, Stenberg A, Läckgren G, Tuvemo T, Hetta J. Sleep of children with enuresis: a polysomnographic study. Pediatrics 1999; 106 (6 Pt 1): 1193–7.
  • Norgaard JP, Hansen JH, Nielsen JB, Rittig S, Djurhuus JC. Nocturnal studies in enuretics. A polygraphic study of sleep-EEG and bladder activity. Scand J Urol Nephrol 1989; 125: 73–8.
  • Mikkelsen EJ, Rapoport JL. Enuresis: Psychopathol-ogy, Sleep Stage, and Drug Response. Urol Clin North Am 1980; 7: 361–77.
  • Kales A, Kales J, Jacobson A, Humphrey FJ, Soldatos CR. Effects of imipramine on enuretic frequency and sleep stages. Pediatrics 1977; 60: 431–6.
  • Finley WW. An EEG study of the sleep of enuretics at three age levels. Clin Electroencephalogr 1971; 2: 35–9.
  • Boyd MM. The depth of sleep in enuretic school-children and in non-enuretic controls. J Psychosom Res 1960; 4: 274–81.
  • Wolfish NM, Pivik RT, Busby KA. Elevated sleep arousal thresholds in enuretic boys: clinical implica-tions. Acta Pediatr 1997; 86: 381–4.
  • Omitz EM, Russell AT, Hanna GL, Gabikian P. Gehricke JG, Song D, Guthrie D. Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry 1999; 45 (11): 1455–66.
  • Hunsballe J. Sleep studes based on electroencephalo-gram energy analysis. Scand J Urol Nephrol 1999; 202 (Suppl): 28–30.
  • Bonnet MH. Effect of sleep disruption on sleep, performance, and mood. Sleep 1985; 8(1): 11–9.
  • Mishne JM. Primary nocturnal enuresis: a psychody-namic clinical perspective. Child Adolesc Soc Work J 1993; 10: 469–95.
  • Friman PC, Handwerk ML, Swearer SM, McGinnis JC, Warzak WJ. Do children with primary nocturnal enuresis have clinically significant behavior problems? Archives of Pediatrics & Adolescent Medicine 1998; 152 (6): 537–9.
  • Baker LB. Symptom treatment and symptom substitu-tion in enuresis. J Abnorm Psychol 1969; 74: 42–9.
  • Couchells SM, Johnson SB, Carter R, Walker D. Behavioral and environmental characteristics of treated and untreated enuretic children and matched none-nuretic controls. J Pediatr 1981; 99: 812–6.
  • Hirasing RA, van Leerdam FJM, Bolk-Bennink LB, Bosch JD. Bedwetting and behavioural and/or emo-tional problems. Acta Pediatr 1997; 86: 1131–4.
  • Werry JS, Cohrssen J. Enuresis - an etiologic and therapeutic study. J Pediatr 1965; 67: 423–31.
  • Fergusson DM, Horwood U. Nocturnal Enuresis and Behavioral Problems in Adolescence: A 15-Year Longitudinal Study. Pediatrics 1994; 94: 662–8.
  • Järvelin MR, Moilanen I, Kangas P. Moring K, et al. Aetiological and precipitating factors for childhood enuresis. Acta Paediatr Scand 1991; 80 (3): 361–9.
  • von Gontard A, Lehmkuhl G. "Enuresis diuma" ist keine Diagnose - neue Ergebnisse zur Klassifikation, Pathogenese und Therapie der funktionellen Hamin-kontinenz im Kinde salter. Prax Kinderpsychol Kinder-psychiatr 1997; 46 (2): 92–112.
  • von Gontard A, Mauer-Mucke K, Pluck J, Berner W, Lehmkuhl G. Clinical behavioral problems in day- and night-wetting children. Pediatr Nephrol 1999; 13 (8): 662–7.
  • Hägglöf B, Andrei) O, Bergstrom E, Marklund L, Wendelius M. Self-esteem before and after treatment in children with nocturnal enuresis and urinary incon-tinence. Scand J Urol Nephrol 1997; 31 (Suppl 183): 79–82.
  • Rey JM, Bird KD, Hensley VR. Bedwetting and psychopathology in adolescents. J Paediatr Child Health 1995; 31(6): 508–12.
  • Robson WL, Jackson JP, Blackhurst D, Leung AK. Enuresis in children with attention-deficit hyperactivity disorder. South Med J 1997; 90 (5): 503–5.
  • Lunsing RJ, Hadders-Algra M, Touwen BCL, Huisjes HJ. Nocturnal enuresis and minor neurological dys-function at 12 years: a follow up study. Dev Med Child Neurol 1991; 33: 439–45.
  • Rittig S, Schaumburg H, Schmidt F, Hunsballe JM, Hansen AF, Kirk J, Rasmussen PV, Djurhuus JC. Long-term home studies of water balance in patients with nocturnal enuresis. Scand J Urol Nephrol 1997; 31 (Suppl 183): 25–27.
  • Norgaard JP, Jonler M, Rittig S, Djurhuus JC. A pharmacodynamic study of desmopressin in patients with nocturnal enuresis. Journal of Urology 1995; 153 (6): 1984–6.
  • Nevéus T, Läckgren G, Tuvemo T, Stenberg A. Osmoregulation and desmopressin pharmacokinetics in enuretic children. Pediatrics 1999; 103 (1): 65–70.
  • Birkasova M, Birkas O, Flynn MJ, Cort JH. Desmo-pressin in the management of nocturnal enuresis in children: a double-blind study. Pediatrics 1978; 62: 970–4.
  • Eller DA, Homsy YL, Austin PF, Tanguay S, Cantor A. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis. Scand J Urol Nephrol 1997; 31 (Suppl 183): 41–5.
  • Evans JH, Meadow SR. Desmopressin for bed wetting: length of treatment, vasopressin secretion, and re-sponse. Arch Dis Child 1992; 67 (2): 184–8.
  • Folwell AJ, Macdiarmid SA, Crowder HJ, Lord AD, Arnold EP. Desmopressin for nocturnal enuresis: urinary osmolality and response. Br J Urol 1997; 80 (3): 480–4.
  • Rushton HG, Heiman AB, Zaontz M, Skoog SJ, Sihelnik S. Response to desmopressin as a function of urine osmolality in the treatment of monosymptomatic nocturnal enuresis: a double-blind prospective study. J Urol 1995; 154 (2 Pt 2): 749–53.
  • Hunsballe JM, Rittig S, Norgaard JP, Pedersen EB, Djurhuus JC. Decreased vasopressin response in nocturnal enuresis during thirst stimulation. In: Nor-gaard JP, Djurhuus JC. Hjälmas K, Hellström A-L. Jorgensen TM, eds. 3rd International Children's Con-tinence Symposium. Sydney, Australia: Wells Medical, 1995: 69–71.
  • Hunsballe J, Rittig S, Pedersen EB, Djurhuus JC. Fluid deprivation in enuresis - effect on urine output and plasma arginine vasopressin. Scand J Urol Nephrol 1999; 33 (Suppl 202): 50–1.
  • Wood CM, Butler RJ, Penney MD, Holland PC. Pulsatile release of Arginine Vasopressin (AVP) and it's effect on response to desmopressin in enuresis. Scand J Urol Nephrol 1994; (Suppl 163): 93–101.
  • Miller M, Moses AM. Radioimmunoassay of urinary antidiuretic hormone in man: response to water load and dehydration in normal subjects. J Clin Endocrinol Metab 1972; 34: 537–45.
  • Shimura N. Urinary aginine vasopressin (AVP) measurement in children: water deprivation test in-corporating urinary AVP. Acta Paediatr Jpn 1993; 35 (4): 320–4.
  • Puri VN. Urinary levels of antidiuretic hormone in nocturnal enuresis. Ind Pediatr J Ind Acad Pediatr 1980; XVII: 675–6.
  • Eller DA, Austin PF, Tanguay S, Homsy YL. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis. Eur Urol 1998; 33 (suppl 3): 25–9.
  • Kirk J, Rasmussen PV, Rittig S, Djurhuus JC. Micturition habits and bladder capacity in normal children and in patients with desmopressin-resistant enuresis. Scand J Urol Nephrol 1995; S173: 49–50.
  • Rushton HG, Heiman AB, Zaontz MR, Skoog SJ, Sihelnik S. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis. J Urol 1996; 156: 651–5.
  • Caione P. Giorgi PL, Passerini-Glazel G, Chiozza ML, Artibani W, Del Gado R, Di Toro R, Ferrara P. Fois A, Graziottin A, Giovannini M, Nappo S, Segni G, Vertucci P. Zacchello F. Desmopressin (DDAVP) and oxybutynin in nocturnal enuresis: results of a multi-centre trial. In: Norgaard JP, Djurhuus JC, Hjälmas K, Hellström A-L, Jorgensen TM, eds. 3rd International Children's Continence Symposium. Sydney, Australia: Wells Medical, 1995: 77–81.
  • Thompson IM, Lauvetz R. Oxybutynin in bladder spasm, neurogenic bladder and enuresis. Urology 1976; 8: 452–4.
  • Persson-Jiinemann CH, Seemann O, Kohrmann KU, Jiinemann KP, Aiken P. Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis. Eur Urol 1993; 24 (1): 92–6.
  • Lovering JS, Tallett SE, McKendry BI. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics 1988; 82: 104–6.
  • Kosar A, Arikan N, Dincel C. Effectiveness of oxybutynin hydrochloride in the treatment of enuresis noctuma. Scand J Urol Nephrol 1999; 33: 115–8.
  • Busby K, Pivik RT. Failure of high intensity auditory stimuli to affect behavioral arousal in children during the first sleep cycle. Pediatr Res 1983; 17: 802–5.
  • Norgaard JP, Hansen JH, Wildschiotz G, Sorensen S, Rittig S, Djurhuus JC. Sleep cystometries in children with nocturnal enuresis. J Urol 1989; 141: 1156–9.
  • Vande Walle J, Hoebeke P. Raes A. Les differences de profit de la diurese nychtémerale. Arch Pediatr 1997; 4 (Suppl 1): 7S–9S.
  • Hogg RJ, Husmann D. The role of family history in predicting response to desmopressin in nocturnal enuresis. J Urol 1993; 150 (2 Pt 1): 444–5.
  • Birch BR, Miller RA. Primary nocturnal enuresis: a urodynamic study spanning three generations. Scand J Urol Nephrol 1995; 29(3): 285–8.
  • Blok C, Venrooij GEMP, Coolsaert BLRA. Dynamics of the ureterovesical junction. J Urol 1986; 136: 1123.
  • van Venrooij EPM, Kamphuis ET, Wolfhogen Diuresis cystometry versus filling cystometry. Neurour-ol Urodyn 1987; 6: 29–36.
  • Pliszka SR, McKracken JT, Maas JVV. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996; 35 (3): 264–72.
  • Klinteberg BA, Magnusson D. Aggressiveness and hyperactive behavior as related to adrenaline axcretion. Eur J Pers 1989; 3: 81–93.
  • Tennes K, Kreye M, Avitable N, Wells R. Behavioral correlates of excreted catecholamines and cortisol in second-grade children. J Am Acad Child Psychiatry 1986; 25: 764–70.
  • Wang RC, Elkins TP, Keech D, Wauquier A, Hubbard D. Accuracy of clinical evaluation in pediatric ob-structive sleep apnea. Otolaryngol Head Neck Surg 1998; 118 (1): 69–73.
  • Krieger J, Follenius M, Sforza E, Brandenberger G, Peter JD. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopresin release during sleep in patients with obstructive sleep apnoea. Clin Sci Colch 1991; 80 (5): 443–9.
  • Warley ARH, Stradling JR. Abnormal diurnal variation in salt and water excretion in patients with obstructive sleep apnea. Clin Sci 1988; 74: 183–5.
  • Glicklich LB. An historical account of enuresis. Pediatrics 1951; 8: 859–86.
  • Belt WR. The History, Folk-lore and Anthropology of Enuresis. Med Pr 1953; 230: 106–9.
  • Friedell A. A reversal of the normal concentration of the urine in children having enuresis. Am J Dis Child 1927; 33: 717–21.
  • Kapoor VK, Saksena PN. Methylamphetamine hydro-chloride (methedrine) in enuresis. Indian J Pediatr 1969; 36 (256): 169–70.
  • Hodge RS, Hutchings HM. Enuresis. Arch Dis Child 1952; 27: 498–513.
  • Olness K. The use of self-hypnosis in the treatment of childhood nocturnal enuresis: a report on 40 patients. Clin Paediatr 1975; 14: 273–9.
  • Matricardi A. Enuresi funzionale. Quale confine tra organico e psicologico? Minerva Pediatr 1996; 48 (6): 259–66.
  • Nye J. Incontinence of urine. M. & S. Rep. 1830; 45: 389.
  • Smith S. Psychological origin and treatment of enuresis. Seattle: University of Washington Press, 1948.
  • Berg IB, Forsythe WI, McGuire R. Response of bed wetting to the enuresis alarm: influence of psychiatric disturbance and maximum functional bladder capacity. Arch Dis Child 1982; 57: 394–6.
  • Houts AC, Peterson JK, Whelan JP. Prevention of relapse in full-spectrum home training for primary enuresis: a component analysis. Behav Ther 1986; 17: 462–9.
  • Morgan RTT. Relapse and therapeutic response in the conditioning treatment of enuresis: a review of recent findings on intermittent reinforcement, overleaming and stimulus intensity. Behav Res Ther 1978; 16: 273–9.
  • Bengtsson B. Sok hjälp tidigt for barn med enures. Rad fran vuxna som haft svar nattväta som barn. - Swedish. Läkartidningen 1997; 94 (4): 245–6.
  • El-Anany FG, Maghraby HA, Shaker SE, Abdel-Moneim AM. Primary nocturnal enuresis: a new approach to conditioning treatment. Urology 1999; 53 (2): 405–8,408–9.
  • Schulpen TWJ, Hirasing RA, de Jong TPVM, van der Heyden AJ, Dijkstra RH, Sukhai RN, Janknegt RA, Scholtmeijer RJ. Going Dutch in nocturnal enuresis. Acta Pediatr 1996; 85: 199–203.
  • Hirasing RA, Bolk-Bennink L, Reus H. Dry bed training by parents: results of a group instruction program. J Urol 1996; 156 (6): 2044–6.
  • Whelan JP, Houts AC. Effects of a waking schedule on primary enuretic children treated with full-spectrum home training. Health Psychol 1990; 9 (2): 164–76.
  • Hoekx L, Wyndaele JJ, Vermandel A. The role of bladder biofeedback in the treatment of children with refractory nocturnal enuresis associated with idiopathic detrusor instability and small bladder capacity. J Urol 1998; 160 (3 Pt 1): 858–60.
  • Ikuhara Y, Watanabe H, Azuma Y, Kawauchi A, Kitamori T, Imada N, Ohne T. (Influential factors on the therapeutic response in the conditioning treatment of enuresis with an original therapeutic machine) - Japanese. Hinyokika Kiyo 1993; 39 (4): 307–11.
  • Watanabe H, Kawauchi A, Kitamori T, Azuma Y. Treatment system for nocturnal enuresis according to an original classification system. Eur Urol 1994; 25 (1): 43–50.
  • Petrican P. Sawan MA. Design of a miniaturized ultrasonic bladder volume monitor and subsequent preliminary evaluation on 41 enuretic patients. IEEE Transactions on Rehabilitation Engineering 1998; 6 (1): 66–74.
  • Pretlow RA. Treatment of nocturnal enuresis with an ultrasound bladder volume controlled alarm device. J Urol 1999; 162 (3 Pt 2): 1224–8.
  • Hjälmis K, Passerini-Glazel G, Chiozza ML. Func-tional daytime incontinence: pharmacological treat-ment. Scand J Urol Nephrol. Suppl. 1992; 141: 108–16.
  • Kruse S, Hellstrom A-L, Hjälmas K. Daytime bladder dysfunction in therapy-resistant nocturnal enuresis. A pilot study in urotherapy. Scand J Urol Nephrol 1999; 33 (1): 49–52.
  • Starfield B, Mellits ED. Increase in functional bladder capacity and improvements in enuresis. J Pediatr 1968; 72: 483–7.
  • Kimmel HD, Kimmel EC. An instrumental condition-ing method for the treatment of enuresis. J Behav Ther Exp Psychiatry 1970; 1: 121–3.
  • Paschallis AP, Kimmel HD, Kimmel EC. Further study of diurnal instrumental conditioning in the treatment of enuresis nocturna. Journal of Behavior Therapy & Experimental Psychiatry 1972; 3: 253–6.
  • Harris LS, Purohit AP. Bladder training and enuresis: A controlled trial. Behavior Research and Therapy 1977; 11: 289–97.
  • Doleys DM. Behavioural treatments for nocturnal enuresis in children: a review of the recent literature. Psychol Bull 1977; 84: 30–54.
  • Geffken G, Johnson SB, Walker D. Behavioral inter-ventions for childhood nocturnal enuresis: the differ-ential effect of bladder capacity on treatment progress and outcome. Health Psychology 1986; 5 (3): 261–72.
  • Ronen T, Abraham Y. Retention control training in the treatment of younger versus older enuretic children. Nurs Res 1996; 45 (2): 78–82.
  • Yannakoyorgos K, Ioannides E, Zahariou A, Anagnos-topoulos D, Kasselas V, Kalinderis A. Management of nocturnal enuresis in children with desmopressin and bladder physiotherapy. Pediatr Surg Int 1998; 13 (4): 281–4.
  • Fielding D. The response of day and night wetting children and children who wet only at night to retention control training and the enuresis alarm. Behaviour Research & Therapy 1980; 18: 305–17.
  • Seth R, Heyman MB. Management of constipation and encopresis in infants and children. Gastroenterol Clin North Am 1994; 23 (4): 621–36.
  • Nolan T, Debelle G, Oberklaid F, Coffey F. Rando-mised trial of laxatives in treatment of childhood encopresis. Lancet 1991; 338 (8766): 523–7.
  • Kramer NR, Bonitati AE, Millman RP. Enuresis and obstructive sleep apnea in the adult. Chest 1998; 114 (2): 634–7.
  • Kurol J, Modin H, Bjerkhoel A. Orthodontic maxillary expansion and its effect on nocturnal enuresis. Angle Orthodontist 1998; 68 (3): 225–32.
  • Timms DJ. Rapid maxillary expansion in the treatment of nocturnal enuresis. Angle-Orthod 1990; 60 (3): 229–34.
  • Egger J, Carter CH, Soothill JF, Wilson J. Effect of diet treatment on enuresis in children with migraine or hyperkinetic behavior. Clin Pediatr (Phila) 1992; 31(5): 302–7.
  • Capozza N, Creti G, De Gennaro M, Minni B, Caione P. Trattamento dell'enuresi nottuma. Studio comparativo tra desmopressina ed agopuntura, usate singolarmente o in assoeiazione. Minerva Pediatr 1991; 43 (9): 577–82.
  • Trsinar B, Kraij B. Maximal electrical stimulation in children with unstable bladder and nocturnal enuresis and/or daytime incontinence: a controlled study. Neurourol Urodyn 1996; 15 (2): 133–42.
  • MacLean REG. Imipramine hydrochloride (Tofranil) and enuresis. Am J Psychiatry 1960; 117: 551.
  • Mahony DT, Laferte RO, Mahoney JE. Observations on sphincter-augmenting effect of imipramine in children with urinary incontinence. Urology 1973; 1: 317–23.
  • Smellie JM, MeGrigor VS, Meadow SR, Rose SJ, Douglas MF. Nocturnal enuresis: a placebo controlled trial of two antidepressant drugs. Arch Dis Child 1996; 75 (1): 62–6.
  • Esperanea M, Gerrard JW. Nocturnal enuresis: com-parison of the effect of imipramine and dietary restrictions on bladder capacity. Can Med Assoc J 1969; 101: 721.
  • Poussaint FA, Ditman SK. A controlled study of imipramine (Tofranil) in the treatment of childhood enuresis. J Pediatr 1965; 67: 283–90.
  • Forsythe WI, Merrell JD. A controlled trial of imipramine (Tofranil) and nortriptyline (Allegron) in the treatment of enuresis. Br J Clin Praet 1969; 23: 210–5.
  • Miller P, Champelli J, Dinello F. Imipramine in the treatment of enuretie school children. A double-blind study. Am J Dis Child 1968; 115: 17–20.
  • Meijer A. Value of imipramine for bed-wetting children. Dis Nerv System 1965; 26: 309–17.
  • Kunin SA, Limbert DJ, Platzker CG. The efficacy of imipramine in the management of enuresis. J Urol 1970; 104: 612–5.
  • Shaffer D, Costello AJ, Hill ID. Control of enuresis with imipramine. Arch Dis Child 1968; 43: 665–71.
  • Martin IG. Imipramine pamoate in the treatment of childhood enuresis. Am J Dis Child 1971; 122: 42–7.
  • Rapoport JL, Mikkelsen EJ, Zavaldil A, Nee L, Gruenau C, Mendelson W, Gillin JC. Childhood enuresis II. psychopathology, tricyclic concentration in plasma, and antienuretie effect. Arch Gen Psychian 1980; 37: 1146–52.
  • Labay P. Boyarsky S. The action of imipramine on the bladder musculature. J Urol 1973; 109: 385–7.
  • Creed KE, Tulloeh AGS. The action of imipramine on the lower urinary tract of the dog. Br J Urol 1982; 54: 5–10.
  • Wein AJ. Pharmacology of the bladder and urethra. In: Stanton T, ed. Surgery of female incontinence. Berlin: Springer, 1980: 185–99.
  • Hägglund TB, Parkkulainen DV. Enuretie children treated with imipramine (Tofranil). Ann Paediatr Fenn 1965; 11: 53–9.
  • Siraeusano S, Tomasi PA, Mandras R, Dilitala G, Monni AM, Belgrano E. Action de 1 'Hydrochloride d'Imipramine sur la fonetion urinaire et sur les paramares sériques chez les enfants enuretiques: etude préliminaire. Prog Urol 1996; 6 (2): 269–73.
  • Puri VN. Increased urinary antidiuretic hormone excretion by imipramine. Exp Clin Endoerinol 1986; 88: 112–4.
  • Fletcher ES, Case LC, Sallee F, Hand DL, Gillettee CP. Prospective study of the electrocardiographic effects of imipramine in children. J Pediatr 1993; 122: 652–4.
  • Zaoral M, Kole J, Sorm F. Amino acids and peptides LXXI. Synthesis of 1-deamino-8-D-amino butyrine vasopressin, 1-deamino-8-D-lysine vasopressin and 1-deamino-8-D-arginine vasopressin. Collection of Czechoslovak Chemical Communications 1967; 32: 1250–7.
  • Tuvemo T. DDAVP in childhood nocturnal enuresis. Acta Pediatr Seand 1978; 67: 753–5.
  • Dimson SB. Desmopressin as a treatment for enuresis. Lancet 1977; 1: 1260.
  • Dimson SB. DDAVP and urine osmolality in refractory enuresis. Arch Dis Child 1986; 61: 1104–1107.
  • Fjellestad-Paulsen A, Wille S, Harris AS. Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child 1987; 62: 674–7.
  • Key DW, Bloom DA, Sanvordenker J. Low-dose DDAVP in nocturnal enuresis. Clin Pediatr Phila 1992; 31(5): 299–301.
  • Matthiesen TB, Rittig S, Djurhuus JC, Norgaard JP. A dose titration, and an open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J Urol 1994; 151 (2): 460–3.
  • Post EM, Richman RA, Blacken PR, Duncan KP, Miller K. Desmopressin response of enuretie children. Effects of age and frequency of enuresis. Am J Dis Child 1983; 137: 962–3.
  • Shu SG, Lii YP, Chi CS. The efficacy of intranasal DDAVP therapy in children with nocturnal enuresis. Chung Hua I Hsueh Tsa Chih (Taipei) 1993; 52 (6): 368–71.
  • Stenberg A, Läckgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics 1994; 94 (6): 841–6.
  • Terho P. Desmopressin in nocturnal enuresis. J Urol 1991; 145 (4): 818–20.
  • Granados EA, Garat JM. Desmopresina: el tratamiento en la enuresis noetuma primaria. Arch Esp Urol 1995; 48 (3): 278–81.
  • Hjälmas K. The Swedish Enuresis Trial (SWEET): long-term use of desmopressin in primary monosymp-tomatie nocturnal enuresis. Preliminary results. In: Norgaard JP, Djurhuus JC, Hjälmas K, Hellsträm A-L, Jorgensen TM, eds. 3rd International Children's Continence Symposium. Sydney, Australia: Wells Medical, 1995: 83–6.
  • Skoog SJ, Stokes A, Turner KL. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enur-esis. J Urol 1997; 158 (3 Pt 2): 1035–40.
  • Hjälmas K, Hanson E, Hellsträm A-L, Kruse S, Sinai U. Long-term treatment with desmopressin in children with primary monosymptomatie nocturnal enuresis: an open multieentre study. Swedish Enuresis Trial (SWEET) Group. Br J Urol 1998; 82 (5): 704–9.
  • Jonat S, Santer R, Sehneppenheim R, Obser T, Eggert P. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenie diabetes insipidus. Arch Dis Child 1999; 81: 57–9.
  • Stegner H, Artman HG, Leake RD, Fisher DA. Does DDAVP (1-desamino-8-D-arginine-vasopressin) cross the blood-CSF barrier? Neuroendoerinology 1983; 37 (4): 262–5.
  • Soelberg SP, Vilhardt H, Gjerris F, Warberg J. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus. Eur J Clin Invest 1984; 14: 435–9.
  • Hjälmas K, Bengtsson B. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr (Phila) 1993; Spec No(Jul): 19–24.
  • Robson HL, Leung AK. Side effects and complications of treatment with desmopressin for enuresis. J Natl Med Assoc 1994; 86 (10): 775–8.
  • Bernstein SA, Williford SL. Intranasal desmopressin-associated hyponatremia: a case report and literature review. J Fam Pract 1997; 44 (2): 203–8.
  • Yarker YE, Goa KL, Fitton A. Oxybutynin. A review of its Pharmacodynamic and Pharmacokinetic properties, and its Therapeutic Use in Detrusor Instability. Drugs & Aging 1995; 6 (3): 243–62.
  • Buttarazzi PJ. Oxybutynin chloride (Ditropan) in enuresis. J Urol 1977; 118: 46.
  • De Grazia E, Cimador M. (Oxybutynin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders) - Italian. Minerva Pediatr 1999; 51(5): 149–52.
  • Banerjee S, Routledge PA, Pugh S, Smith PM. Poisoning with oxybutynin. Human & Experimental Toxicology 1991; 10 (3): 225–6.
  • Jonville AP, Dutertre JP, Barbellion M, Autret E. Effects indesirables du chlorure d'oxybutynine (Ditro-pan) en pediatrie. Archives Francaises de Pediatrie 1993; 50 (1): 27–9.
  • Hampson SJ, Noble JG, Rickards D, Milroy EJ. Does residual urine predispose to urinary tract infection? Br J Urol 1992; 70 (5): 506–8.
  • Ruscin JM, Morgenstern NE. Tolterodine use for symptoms of overactive bladder. Ann Pharmacother 1999; 33 (10): 1073–82.
  • Abrams P, Freeman R, Anderstrom C, Mattiasson A. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 1998; 81(6): 801–10.
  • Drutz HP, Appell RA, Gleason D, Klimberg I, Radomski S. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct 1999; 10 (5): 283–9.
  • Larsson G, Hallen B, Nilvebrant L. Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data. Urology 1999; 53 (5): 990–8.
  • Millard R, Tuttle J, Moore K, Susset J, Clarke B, Dwyer P, Davis BE. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity. J Urol 1999; 161 (5): 1551–5.
  • Rentzhog L, Stanton SL, Cardozo L, Nelson E, Fall M, Abrams P. Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study. Br J Urol 1998; 81(1): 42–8.
  • Goldman LM, Malavazos A. The hormonal treatment of enuresis. Urol Cutan Rev 1936; 40: 729–41.
  • Schultz FW, Anderson CE. Endocrine treatment of enuresis. J Clin Endocrinol 1943; 3: 405–12.
  • Kugelmass IN. Androgenic arrest of familial enuresis in 75 children. J Clin Endocrinol 1946; 6: 823–9.
  • El-Sadr A, Sabry AA, Abdel-Rahman M, El-Barnacha-wy R, Koraitim M. Treatment of primary nocturnal enuresis by oral androgen mesterolone. A clinical and cystometric study. Urology 1990; 36 (4): 331–5.
  • Varan B, Sag ci U, Ozen S, Bakkaloglu A, Besbas N. Efficacy of oxybutynin, pseudoephedrine and indo-methacin in the treatment of primary nocturnal enuresis. Turk J Pediatr 1996; 38 (2): 155–9.
  • El Hemaly AK. Nocturnal enuresis: pathogenesis and treatment. Int Urogynecol J Pelvic Floor Dysfunct 1998; 9 (3): 129–31.
  • Kimura Y, Sasaki Y, Hamada K, Fukui H, Ukai Y, Yoshikuni Y, Kimura K, Sugaya K, Nishizawa O. Mechanisms of the suppression of the bladder activity by flavoxate. Int J Urol 1996; 3 (3): 218–27.
  • Jonas U, Petri E, Kissel J. Effect of flavoxate on hyperactive detrusor muscle. Eur Urol 1979; 5: 106–9.
  • Batislam E, Nohoglu B, Peskircioglu L, Emir L, Uygur C, Germiyanoglu C, Erol D. A prostaglandin synthesis inhibitor, diclofenac sodium in the treatment of primary nocturnal enuresis. Acta Urol Belg 1995; 63 (3): 35–8.
  • Natochin IV, Kuznetsova AA. (Nocturnal enuresis as a manifestation of autocoidosis) - Russian. Terapevti-cheskii Arkhiv 1998; 69 (12): 67–72.
  • Bradbury MG, Meadow SR. Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis. Acta Pediatr 1995; 84: 1014–8.
  • Läckgren G, Hjälmas K, van Gool J, von Gontard A, de Gennaro M, Lottman H, Terho P. Nocturnal enuresis: a suggestion for a European treatment strategy. Acta Paediatr 1999; 88: 1–7.
  • Rockney RM, McQuade WH, Days AL. The plain abdominal roentgenogram in the management of encopresis. Arch Pediatr Adolesc Med 1995; 149 (6): 623–7.
  • Beach PS, Beach RE, Smith LR. Hyponatremic seizures in a child treated with desmopressin to control enuresis. A rational approach to fluid intake. Clinical Pediatrics 1992; 31 (S9ep): 566–9.
  • Robson WL, Norgaard JP, Leung AK. Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 1996; 155 (11): 959–62.
  • Dahlstrom A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 1964; 62 (Suppl 232): 1–55.
  • Jones BE. Noradrenergic locus coeruleus neurons: their distant connections and their relationship to neighbor-ing (including cholinergic and GABAergic) neurons of the central gray and reticular formation. Prog Brain Res 1991; 88: 15–30.
  • Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 1971; (Suppl 367): 1–49.
  • Segal M, Bloom FE. The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity. Brain res 1976; 107: 513–25.
  • Biegon A, Rainbow TC. Localization and characteriza-tion of (3H) desmethylimipramine binding sites in rat brain by quantitative autoradiography. J Neurosci 1983; 3: 1069–76.
  • Danysz W, Kostowski W, Hauptmann M. Evidence for the locus coeruleus involvement in desipramine action in animal models of depression. Pol J Pharmacol Pharm 1985; 37 (6): 855–64.
  • Yoshimura N, Sasa M, Yoshida O, Takaori S. Mediation of micturition reflex by central norepinephr-Me from the locus coeruleus in the cat. J Urol 1990; 143 (4): 840–3.
  • Koyama Y, Imada N, Kayama Y, Kawauchi A, Watanabe H. How does the distention of urinary bladder cause arousal? Psychiatry Clin Neurosci 1998; 52 (2): 142–5.
  • Watanabe H, Imada N, Kawauchi A, Koyama Y, Shirakawa S. Physiological background of enuresis type I. A preliminary report. Scand J Urol Nephrol 1997; 31 (Suppl 183): 7–10.
  • Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Micturitional disturbance and the pontine tegmental lesion: urodynamic and MRI analyses of vascular cases. J Neurol Sci 1996; 141 (1-2): 105–10.
  • Bowden DM, German DC, Poynter WD. An autoradio-graphic, semistereotaxic mapping of major projections from locus coeruleus and adjacent nuclei in Macaca mulatta. Brain Res 1978; 145: 257–76.
  • Sladek JRJ, Zimmerman EA. Simultaneous monoamine histofluorescence and neuropeptide immunocytochem-istry. IV. Catecholamine innervation of vasopressin and oxytocin neurons in the rhesus monkey hypothalamus. Brain Res Bull 1982; 9: 431–40.
  • Jones BJ, Moore RY. Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 1977; 127: 23–53.
  • Sawchenko PE, Swanson LW. Central noradrenergic pathways for the integration of hypothalamic neuro-endocrine and autonomic responses. Science 1981; 214: 685–7.
  • Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei of the rat. Brain Res Rev 1982; 4: 275–325.
  • Swanson LW, Sawchenko PE, Berod A, Hartman BK, Belle KB, Vanorden DE. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus. J Comp Neurol 1981; 196: 271–85.
  • Lightman SL, Todd K, Everitt BJ. Ascending nor-adrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and vasopressin secretion. Exp Brain Res 1984; 55: 145–51.
  • Berecek KH, Olpe HR, Hofbauer KC. Responsiveness of locus coeruleus neurons in hypertensive rats to vasopressin. Hypertension 1987; 9: III 110–3.
  • De Luca LAJ, Franci CR, Saad WA, Camargo LA, Antunes-Rodrigues J. Natriuresis induced by choliner-gic stimulation of the locus coeruleus in the rat. Physiol Behav 1990; 47(4): 605–10.
  • Osumi Y, Oishi R, Fujiwara H, Takaori S. Hyperdipsia induced by bilateral destruction of the locus coeruleus in rats. Brain Research 1975; 86: 419–27.
  • Yakmci C, Miingen B, Durmaz Y, Balbay D, Karabiber H. Autonomic nervous system functions in children with nocturnal enuresis. Brain Dev 1997; 19: 485–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.